Use of structure-based virtual screening in the investigation of novel human sialidase inhibitors

Medicinal Chemistry Research

Volumn 19, Issue 9, 2010, Pages 1273-1286

  Magesh, Sadagopan ^a,c   Moriya, Setsuko ^b   Suzuki, Tohru ^a   Miyagi, Taeko ^b   Ishida, Hideharu ^a   Kiso, Makoto ^a,c  

^a GIFU UNIVERSITY   (Japan)

^b MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Docking; Inhibitor design; Sialic acid; Sialidase; Virtual screening

Indexed keywords

2 DEOXY 2,3 DEHYDRO I ACETYLNEURAMINIC ACID; DICARBOXYLIC ACID; FURAN; GSC 649; GSC 672; GSC 697; SIALIDASE; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG STRUCTURE; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50;

EID: 78650177875     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9269-6     Document Type: Article

References (24)

1. KE Achyuthan AM Achyuthan 2001 Comparative enzymology, biochemistry and pathophysiology of human exo-alpha-sialidases (neuraminidases) Comp Biochem Physiol B Biochem Mol Biol 129 29 64 1:STN:280:DC%2BD3MvkvVCksQ%3D%3D 10.1016/S1096-4959(01)00372-4 11337249 (Pubitemid 32401124)
2. LM Chavas C Tringali P Fusi B Venerando G Tettamanti R Kato E Monti S Wakatsuki 2005 Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition J Biol Chem 280 469 475 1:CAS:528:DC%2BD2cXhtFGgu7nP 15501818
3. Corfield AP, Schauer R (1982) In: Schauer R (ed) Sialic acids: chemistry, metabolism and function. Cell biology monographs. Springer-Verlag, Wien, pp 5-55
4. K Hata K Koseki K Yamaguchi S Moriya Y Suzuki S Yingsakmongkon G Hirai M Sodeoka M von Itzstein T Miyagi 2008 Limited inhibitory effects of oseltamivir and zanamivir on human sialidases Antimicrob Agents Chemother 52 3484 3491 1:CAS:528:DC%2BD1cXht1SrtbjO 10.1128/AAC.00344-08 18694948
5. Igdoura SA, Trigatti BL (2007) Sialidase inhibitors for the treatment of cardiovascular disease. WIPO Patent Application WO/2007/036041
6. SA Igdoura A Yang D DeSA BL Trigatti 2007 PO22-699: prevention of atherosclerosis in apoe knockout mice using sialidase inhibitors: a new class of anti-atherogenic drugs Athero Suppl 8 187 10.1016/S1567-5688(07)71709-9
7. JJ Irwin BK Shoichet 2005 ZINC, a free database of commercially available compounds for virtual screening J Chem Inf Model 45 177 182 1:CAS:528:DC%2BD2cXhtVOjt77J 10.1021/ci049714+ 15667143 (Pubitemid 40736970)
8. DB Kitchen H Decornez JR Furr J Bajorth 2004 Docking and scoring in virtual screening for drug discovery: methods and applications Nat Rev Drug Discov 3 935 949 1:CAS:528:DC%2BD2cXptFemtrg%3D 10.1038/nrd1549 15520816 (Pubitemid 39529931)
9. S Magesh T Suzuki T Miyagi H Ishida M Kiso 2006 Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors J Mol Graph Model 25 196 207 1:CAS:528:DC%2BD28Xps1Gis78%3D 10.1016/j.jmgm.2005.12.006 16427342 (Pubitemid 44345275)
10. S Magesh S Moriya T Suzuki T Miyagi H Ishida M Kiso 2008 Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: Selective inhibitors of lysosomal sialidase (NEU1) Bioorg Med Chem Lett 18 532 537 1:CAS:528:DC%2BD1cXosFWgtQ%3D%3D 10.1016/j.bmcl.2007.11.084 18068975
11. S Magesh S Moriya T Suzuki T Miyagi H Ishida M Kiso 2009 Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5- acylamido-2-fluoro benzoic acids Bioorg Med Chem 17 4595 4603 1:CAS:528:DC%2BD1MXnt1Gqs7Y%3D 10.1016/j.bmc.2009.04.065 19450982
12. MC Mann R Thomson JC Dyason S McAtamney M von Itzstein 2006 Modelling, synthesis and biological evaluation of novel glucuronide-based probes of Vibrio cholerae sialidase Bioorg Med Chem 14 1518 1537 1:CAS:528:DC%2BD28XmsVGiuw%3D%3D 10.1016/j.bmc.2005.10.004 16275104 (Pubitemid 43120288)
13. Miyagi T, Yamaguchi K (2008) In: Kamerling J, Boons G-J, Lee Y, Suzuki A, Taniguchi N, Voragen AGJ (eds) Comprehensive glycoscience, from chemistry to biology, vol 3. Elsevier, Oxford, pp 297-323
14. T Miyagi K Kato S Ueno T Wada 2004 Aberrant expression of sialidase in cancer Trends Glycosci Glycotechnol 16 371 381 1:CAS:528:DC%2BD2MXhsFajtbs%3D
15. T Miyagi T Wada K Yamaguchi K Hata 2004 Sialidase and malignancy: a minireview Glycoconj J 20 189 198 1:CAS:528:DC%2BD2cXjtFKqtr8%3D 10.1023/B:GLYC.0000024250.48506.bf 15090732
16. Miyagi T, Wada T, Yamaguchi K (2007) Medicinal composition for treating cancer or diabetes. European Patent Application EP1813289
17. J Neres P Bonnet PN Edwards PL Kotian A Buschiazzo PM Alzari RA Bryce KT Douglas 2007 Benzoic acid and pyridine derivatives as inhibitors of trypanosoma cruzi trans-sialidase Bioorg Med Chem 15 2106 2119 1:CAS:528: DC%2BD2sXhtlOnt74%3D 10.1016/j.bmc.2006.12.024 17218104 (Pubitemid 46176624)
18. Saito M, Yu RK (1995) In: Rosenburg A (ed) Biology of the sialic acids. Plenum Press, New York, pp 261-314
19. A Sasaki K Hata S Suzuki M Sawada T Wada K Yamaguchi M Obinata H Tateno H Suzuki T Miyagi 2003 Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice J Biol Chem 278 27896 27902 1:CAS:528:DC%2BD3sXlsFKkurs%3D 10.1074/jbc.M212200200 12730204 (Pubitemid 36899982)
20. R Schauer 1985 Sialic acids and their role as biological masks Trends Biochem Sci 10 357 360 1:CAS:528:DyaL2MXlslCju7c%3D 10.1016/0968-0004(85)90112-4 (Pubitemid 16220327)
21. R Schauer 2000 Achievements and challenges of sialic acid research Glycoconj J 17 485 499 1:CAS:528:DC%2BD3MXksVOgtL8%3D 10.1023/A:1011062223612 11421344 (Pubitemid 32480340)
22. Schauer R, Kelm S, Reuter G, Roggentin P, Shaw L (1995) In: Rosenburg A (ed) Biology of the sialic acids. Plenum Press, New York, pp 7-67
23. CM Venkatachalam X Jiang T Oldfield M Waldman 2003 LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites J Mol Graph Model 21 289 307 1:CAS:528:DC%2BD38XptlWmuro%3D 10.1016/S1093- 3263(02)00164-X 12479928 (Pubitemid 35441326)
24. M Von Itzstein WY Wu GB Kok MS Pegg JC Dyason B Jin TV Phan ML Smythe HF White SW Oliver PM Colman JN Varghese DM Ryan JM Woods RC Bethell VJ Hotham JM Cameron CR Penn 1993 Rational design of potent sialidase-based inhibitors of influenza virus replication Nature 363 418 423 10.1038/363418a0 (Pubitemid 23179386)